The Australian medical landscape is buzzing with the arrival of retatrutide, a novel dual GIP and GLP-1 receptor showing impressive results in early trials for treating obesity. This therapy suggests a https://socialwebnotes.com/story6931917/retatrutide-australia-a-emerging-solution-for-weight-management